Literature DB >> 21801651

Reston Ebolavirus antibodies in bats, the Philippines.

Satoshi Taniguchi, Shumpei Watanabe, Joseph S Masangkay, Tsutomu Omatsu, Tetsuro Ikegami, Phillip Alviola, Naoya Ueda, Koichiro Iha, Hikaru Fujii, Yoshiyuki Ishii, Tetsuya Mizutani, Shuetsu Fukushi, Masayuki Saijo, Ichiro Kurane, Shigeru Kyuwa, Hiroomi Akashi, Yasuhiro Yoshikawa, Shigeru Morikawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801651      PMCID: PMC3381561          DOI: 10.3201/eid1708.101693

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Filoviruses cause highly lethal hemorrhagic fever in humans and nonhuman primates, except for Reston Ebolavirus (REBOV), which causes severe hemorrhagic fever in macaques (,). REBOV epizootics among cynomolgus macaques occurred in 1989, 1990, 1992, and 1996 () and among swine in 2008 (). African fruit bats have been suggested to be natural reservoirs for Zaire Ebolavirus and Marburg virus (–). However, the natural reservoir of REBOV in the Philippines is unknown. Thus, we determined the prevalence of REBOV antibody–positive bats in the Philippines. Permission for this study was obtained from the Department of Environment and Natural Resources, the Philippines, before collecting bat specimens. Serum specimens from 141 wild-caught bats were collected at several locations during 2008–2009. The bat species tested are summarized in the Table. Captured bats were humanely killed and various tissues were obtained. Carcasses were then provided to the Department of Environment and Natural Resources for issuance of a transport permit.
Table

REBOV-specific IgG in Rousettus amplexicaudatus bats and other bats, the Philippines*

Bat IDCollection siteELISA optical density
IFA titer
REBOV NPREBOV GPREBOV NPREBOV GP
1539FD 2.13 –0.21 1,280 <20
1632FQ1 0.88 0.2<20<20
1642FQ10.36 5.22 <20 20
1643FQ1 1.26 0.92 <20<20
1651FQ1 1.61 1.02 <20<20
1657FQ1–0.45 1.69 <20<20
1660FQ1 3.8 2.51 640 <20

*Cutoff optical density of ELISA was 0.82 (sum of optical densities at serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400). Values in boldface are positive results. REBOV, Reston Ebolavirus; Ig, immunoglobulin; IFA, indirect immunofluorescence assay; ID, identification; NP, nucleoprotein; GP, glycoprotein; FD, forest of Diliman at the University of the Philippines Diliman campus; FQ1, forest at the Agricultural College in Province of Quezon, the Philippines. The other 9 R. amplexicaudatus bats collected at FQ1 had negative results for all assays. The following bat species also had negative results: 5 Eonycteris spelaea, 35 Cynopterus brachyotis, 38 Ptenochirus jagoli, 6 Haplonycteris fischeri, 2 Macroglossus minimus, 2 Rhinolophus rufus, 1 Rhinolophus arcuatus, 9 Emballonura alecto, 2 Pipistrellus javanicus, 5 Scotophilus kuhlii, 8 Miniopterus australis, 8 M. schreibersi, 1 M. tristis tritis, 1 Hipposideros diadema, 1 Myotis macrotarsus, and 1 bat of unknown species.

*Cutoff optical density of ELISA was 0.82 (sum of optical densities at serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400). Values in boldface are positive results. REBOV, Reston Ebolavirus; Ig, immunoglobulin; IFA, indirect immunofluorescence assay; ID, identification; NP, nucleoprotein; GP, glycoprotein; FD, forest of Diliman at the University of the Philippines Diliman campus; FQ1, forest at the Agricultural College in Province of Quezon, the Philippines. The other 9 R. amplexicaudatus bats collected at FQ1 had negative results for all assays. The following bat species also had negative results: 5 Eonycteris spelaea, 35 Cynopterus brachyotis, 38 Ptenochirus jagoli, 6 Haplonycteris fischeri, 2 Macroglossus minimus, 2 Rhinolophus rufus, 1 Rhinolophus arcuatus, 9 Emballonura alecto, 2 Pipistrellus javanicus, 5 Scotophilus kuhlii, 8 Miniopterus australis, 8 M. schreibersi, 1 M. tristis tritis, 1 Hipposideros diadema, 1 Myotis macrotarsus, and 1 bat of unknown species. We used immunoglobulin (Ig) G ELISAs with recombinant nucleoprotein (NP) and glycoprotein (GP) of REBOV () to determine REBOV antibody prevalence. REBOV NP and GP were expressed and purified from Tn5 cells infected with recombinant baculoviruses AcResNP and AcResGPDTM, which express NP and the ectodomain of GP with the histidine tag at its C-terminus. We also used histidine-tagged recombinant Crimean-Congo hemorrhagic fever virus NP as a negative control antigen in the IgG ELISA to confirm specificity of reactivity. In IgG ELISAs for bat specimens, positive results were detected by using rabbit anti-bat IgG and horseradish peroxidase–conjugated anti-rabbit IgG. Anti-bat (Rousettus aegyptiacus) rabbit IgG strongly cross-reacts with IgGs of other bat species, including insectivorous bats (). Bat serum samples were 4-fold serially diluted (1:100–1:6,400) and tested by using IgG ELISAs. Results of IgG ELISAs were the sum of optical densities at serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400. Cutoff values (0.82 for both IgG ELISAs) were determined by using serum specimens from REBOV antibody–negative bats. Among 16 serum samples from R. amplexicaudatus bats, 5 (31%) captured at either the forest of Diliman (14°38′N, 121°2′E) or the forest of Quezon (14°10′N, 121°50′E) had positive results in the IgG ELISA for REBOV NP, and 5 (31%) captured at the forest of Quezon had positive results in the IgG ELISA for REBOV GP. The REBOV NP antibody–positive bats serum samples were confirmed to be NP antibody positive in the IgG ELISA by using glutathione-S-transferase–tagged partial REBOV NP antigen (). Three samples had positive results in both IgG ELISAs (Table). Serum samples from other bat species had negative results in IgG ELISAs. All bat serum samples were also tested by indirect immunofluorescence assays (IFAs) that used HeLa cells expressing NP and GP (). In the IFAs, 2 samples from R. amplexicaudatus bats captured at the forest of Diliman and the forest of Quezon had high titers (1,280 and 640, respectively) of NP-specific antibodies, and 1 sample from an R. amplexicaudatus bat captured at the forest of Quezon had a positive result in the GP-specific IFA (titer 20). All IFA-positive samples were also positive in the IgG ELISA (Table). The forest of Diliman is ≈30 km from the monkey facility and the Bulacan farm where REBOV infections in monkeys and swine, respectively, were detected. The forest of Quezon is ≈60 km from the monkey facility. Samples from other bat species had negative results in IFAs. We also performed heminested reverse transcription PCR specific for the REBOV NP gene with spleen specimens from all 16 R. amplexicaudatus bats but failed to detect any REBOV-specific amplicons. REBOV-specific antibodies were detected only in R. amplexicaudatus bats, a common species of fruit bat, in the Philippines. In Africa, R. aegyptiacus bats, which are genetically similar to R. amplexicaudatus bats, have been shown to be naturally infected with Zaire Ebolavirus and Marburg virus. Thus, R. amplexicaudatus bats are a possible natural reservoir of REBOV. However, only 16 specimens of R. amplexicaudatus bats were available in this study, and it will be necessary to investigate more specimens of this species to detect the REBOV genome or antigens to conclude the bat is a natural reservoir for REBOV. We have shown that R. amplexicaudatus bats are putatively infected with REBOV or closely related viruses in the Philippines. Antibody-positive bats were captured at the sites near the study areas, where REBOV infections in cynomolgus monkeys and swine have been identified. Thus, bats are a possible natural reservoir of REBOV. Further analysis to demonstrate the REBOV genome in bats is necessary to conclude that the bat is a reservoir of REBOV.
  10 in total

1.  Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells.

Authors:  Tetsuro Ikegami; Masayuki Saijo; Masahiro Niikura; Mary E G Miranda; Alan B Calaor; Marvin Hernandez; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

2.  Molecular evolution inferred from immunological cross-reactivity of immunoglobulin G among Chiroptera and closely related species.

Authors:  Tsutomu Omatsu; Yoshiyuki Ishii; Shigeru Kyuwa; Elizabeth G Milanda; Keiji Terao; Yasuhiro Yoshikawa
Journal:  Exp Anim       Date:  2003-10

3.  Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus.

Authors:  T Ikegami; M Saijo; M Niikura; M E Miranda; A B Calaor; M Hernandez; D L Manalo; I Kurane; Y Yoshikawa; S Morikawa
Journal:  Epidemiol Infect       Date:  2003-06       Impact factor: 2.451

Review 4.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

6.  Discovery of swine as a host for the Reston ebolavirus.

Authors:  Roger W Barrette; Samia A Metwally; Jessica M Rowland; Lizhe Xu; Sherif R Zaki; Stuart T Nichol; Pierre E Rollin; Jonathan S Towner; Wun-Ju Shieh; Brigid Batten; Tara K Sealy; Consuelo Carrillo; Karen E Moran; Alexa J Bracht; Gregory A Mayr; Magdalena Sirios-Cruz; Davinio P Catbagan; Elizabeth A Lautner; Thomas G Ksiazek; William R White; Michael T McIntosh
Journal:  Science       Date:  2009-07-10       Impact factor: 47.728

7.  Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.

Authors:  M E Miranda; T G Ksiazek; T J Retuya; A S Khan; A Sanchez; C F Fulhorst; P E Rollin; A B Calaor; D L Manalo; M C Roces; M M Dayrit; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

Review 8.  Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).

Authors:  Shigeru Morikawa; Masayuki Saijo; Ichiro Kurane
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2007-07-03       Impact factor: 2.268

9.  Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus.

Authors:  Xavier Pourrut; Marc Souris; Jonathan S Towner; Pierre E Rollin; Stuart T Nichol; Jean-Paul Gonzalez; Eric Leroy
Journal:  BMC Infect Dis       Date:  2009-09-28       Impact factor: 3.090

10.  Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

Authors:  Jonathan S Towner; Brian R Amman; Tara K Sealy; Serena A Reeder Carroll; James A Comer; Alan Kemp; Robert Swanepoel; Christopher D Paddock; Stephen Balinandi; Marina L Khristova; Pierre B H Formenty; Cesar G Albarino; David M Miller; Zachary D Reed; John T Kayiwa; James N Mills; Deborah L Cannon; Patricia W Greer; Emmanuel Byaruhanga; Eileen C Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W Tappero; Sherif R Zaki; Thomas G Ksiazek; Stuart T Nichol; Pierre E Rollin
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

  10 in total
  40 in total

1.  Biannual birth pulses allow filoviruses to persist in bat populations.

Authors:  David T S Hayman
Journal:  Proc Biol Sci       Date:  2015-03-22       Impact factor: 5.349

2.  Ebola virus disease: history, epidemiology and outbreaks.

Authors:  Jacqueline Weyer; Antoinette Grobbelaar; Lucille Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

Review 3.  Current ebola vaccines.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Expert Opin Biol Ther       Date:  2012-05-05       Impact factor: 4.388

Review 4.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

Review 5.  An update on the use of antibodies against the filoviruses.

Authors:  Erica Ollmann Saphire
Journal:  Immunotherapy       Date:  2013-11       Impact factor: 4.196

6.  Phylogenetic assessment of filoviruses: how many lineages of Marburg virus?

Authors:  A Townsend Peterson; Mark T Holder
Journal:  Ecol Evol       Date:  2012-07-01       Impact factor: 2.912

7.  Serological evidence of Ebola virus infection in Indonesian orangutans.

Authors:  Chairul A Nidom; Eri Nakayama; Reviany V Nidom; Mohamad Y Alamudi; Syafril Daulay; Indi N L P Dharmayanti; Yoes P Dachlan; Mohamad Amin; Manabu Igarashi; Hiroko Miyamoto; Reiko Yoshida; Ayato Takada
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

8.  Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines.

Authors:  Satoshi Taniguchi; Yusuke Sayama; Noriyo Nagata; Tetsuro Ikegami; Mary E Miranda; Shumpei Watanabe; Itoe Iizuka; Shuetsu Fukushi; Tetsuya Mizutani; Yoshiyuki Ishii; Masayuki Saijo; Hiroomi Akashi; Yasuhiro Yoshikawa; Shigeru Kyuwa; Shigeru Morikawa
Journal:  BMC Vet Res       Date:  2012-10-11       Impact factor: 2.741

Review 9.  Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.

Authors:  Shuetsu Fukushi; Hideki Tani; Tomoki Yoshikawa; Masayuki Saijo; Shigeru Morikawa
Journal:  Viruses       Date:  2012-10-12       Impact factor: 5.048

10.  Serological evidence of ebolavirus infection in bats, China.

Authors:  Junfa Yuan; Yuji Zhang; Jialu Li; Yunzhi Zhang; Lin-Fa Wang; Zhengli Shi
Journal:  Virol J       Date:  2012-10-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.